Live TVLatestMarketsBusinessEconomyResearch ReportsBeepsPersonal FinanceIndiaWorld
LIVE TV
App
Social
Hello Reader
Newsletters
Watchlist
Misc
About
Support
Terms of Use
Privacy Policy
Set as Trusted Source
on Google Search
Google Badge
  • Home
  • Search

'Search' - 1,000 News Result(s)

  • Gold Price Today: MCX Gold Trades Lower At Rs 1.44 Lakh As US-Iran Tensions Continue
    Gold Price Today: MCX Gold Trades Lower At Rs 1.44 Lakh As US-Iran Tensions Continue

    MCX gold August futures contract dipped 0.26% to Rs 1,44,916 per 10 grams, while the MCX silver September futures rose 0.05% to Rs 2,26,500 per kg.

    • Jul 10, 2026 14:36 pm IST
    • Markets
    • Yukta Baid
  • Final Day! Kusumgar IPO GMP Signals Strong Listing Pop Amid Robust Investor Demand
    Final Day! Kusumgar IPO GMP Signals Strong Listing Pop Amid Robust Investor Demand

    As bidding for the Kusumgar IPO enters its final day, the latest grey market premium signals healthy listing gains for investors.

    • Jul 10, 2026 14:23 pm IST
    • Markets
    • NDTV Profit News
  • Gold Prices In India: Check Rates In Mumbai, Delhi, Chennai, Kolkata, Bangalore And Hyderabad
    Gold Prices In India: Check Rates In Mumbai, Delhi, Chennai, Kolkata, Bangalore And Hyderabad

    Gold prices closed at Rs 1,45,350 per 10 grams on the Multi Commodity Exchange (MCX) on Thursday, July 9.

    • Jul 10, 2026 14:17 pm IST
    • Markets
    • Maumita Mitra
  • TCS Target Price Revised After Q1 Results; Systematix Sees Gradual Recovery Ahead — Check Upside, Ratings
    TCS Target Price Revised After Q1 Results; Systematix Sees Gradual Recovery Ahead — Check Upside, Ratings

    The brokerage believes that TCS is likely to minimise its revenue growth gap with peers in FY27E, supported by net-new large deals, and potential pick-up in developed markets.

    • Jul 10, 2026 14:10 pm IST
    • Markets
    • Systematix Institutional Equities
  • TCS Share Price in Focus After Q1 FY27 Results, Dividend Announcement
    TCS Share Price in Focus After Q1 FY27 Results, Dividend Announcement

    TCS reported constant-currency revenue growth of 0.4% quarter-on-quarter and 3.2% year-on-year during the June quarter.

    • Jul 10, 2026 14:04 pm IST
    • Markets
    • Tanmay Tiwary
  • Stocks To Buy: Check Kush Bohra's Top Picks Of The Day | July 10, 2026
    Stocks To Buy: Check Kush Bohra's Top Picks Of The Day | July 10, 2026

    Technical analyst Kush Bohra shares his top picks for the day.

    • Jul 10, 2026 14:01 pm IST
    • Markets
    • NDTV Profit Desk
  • Attention Travellers: Central Railway Cancels These Trains Till July 17 After Lonavala-Karjat Landslide
    Attention Travellers: Central Railway Cancels These Trains Till July 17 After Lonavala-Karjat Landslide

    Central Railway has cancelled several long-distance, intercity and special trains until July 17 after landslides disrupted the LonavalaKarjat section.

    • Jul 10, 2026 13:54 pm IST
    • India
    • Aishwarya Singh
  • Dixon Tech Remains Top Pick For JP Morgan After Vivo JV Approval; 39% Upside Seen — Check Target Price
    Dixon Tech Remains Top Pick For JP Morgan After Vivo JV Approval; 39% Upside Seen — Check Target Price

    JPMorgan raised its Dixon Technologies target price to Rs 16,700 after the Vivo JV approval, implying 39% upside and triggering sharp revenue and earnings upgrades.

    • Jul 10, 2026 13:48 pm IST
    • Markets
    • Yukta Baid
  • Trump On Target Again? Israel Shares Intel On New Iranian Assassination Plot: Report
    Trump On Target Again? Israel Shares Intel On New Iranian Assassination Plot: Report

    Addressing threats to his life at a NATO summit news conference in Ankara on Wednesday, Trump said he was on 'whatever list' Iran maintained, adding that he had 'been a bit lucky' so far.

    • Jul 10, 2026 13:45 pm IST
    • World
    • Vaishnavi Mishra
  • Dr. Reddy's Downgraded By Systematix After Semaglutide Setback; Target Price Cut — Should You Buy Or Hold?
    Dr. Reddy's Downgraded By Systematix After Semaglutide Setback; Target Price Cut — Should You Buy Or Hold?

    The brokerage's cautious stance comes after Dr Reddy's disclosed that it had temporarily suspended commercial supplies of Semaglutide injections following the identification of an out-of-specification impurity during the API scale-up validation process

    • Jul 10, 2026 13:44 pm IST
    • Markets
    • Systematix Institutional Equities
QUICK LINKS
LatestWatchlistBreakout AlertsLive TVFuturesOptionsIPOs Tracker
QUICK LINKS
LatestWatchlistBreakout AlertsLive TVFuturesOptionsIPOs Tracker
ALL SECTIONS
MarketsBusinessEconomyResearch ReportsPersonal FinanceIndiaWorldTechnologySportsLifestyleScienceVideosGold PriceSilver PriceFuel PricesCalculators
ALL SECTIONS
MarketsBusinessEconomyResearch ReportsPersonal FinanceIndiaWorldTechnologySportsLifestyleScienceVideosGold PriceSilver PriceFuel PricesCalculators
STAY UPDATED
NewslettersTelegramPodcastsWhatsapp
STAY UPDATED
NewslettersTelegramPodcastsWhatsapp
OUR NEWSLETTERS
Sign Up

By signing up you agree to the Terms & Conditions of NDTV Profit

television
Get Support
Feel free to reach out to us
Follow Us
Note : All Stock Exchange data is delayed upto 3 mins
DISCOVER US FASTER
NewGoogle Badge
App  Scanner
DOWNLOAD THE APP
Play StoreApp Store
About us
Terms of Use
Privacy Policy
Sitemap
RSS
About us
Terms of Use
Privacy Policy
Sitemap
RSS
2026 © NDTV Profit. All Rights Reserved